🇺🇸 FDA
Patent

US 10617706

Compounds for cancer chemotherapeutic sensitization

granted A61KA61K31/7068A61K45/06

Quick answer

US patent 10617706 (Compounds for cancer chemotherapeutic sensitization) held by Regents of the University of Minnesota expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Apr 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/7068, A61K45/06, A61K47/02, A61K47/10